The annual general meeting ("AGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held today on 5 May 2022 in Stockholm and the following resolutions were passed by the meeting.
Adoption of the income statement and the balance sheet
The AGM resolved to adopt the income statement and the balance sheet in FRISQ and the consolidated income statement and the consolidated balance sheet.
Allocation of profit
The AGM resolved that no dividend would be paid to the shareholders and that the previously accrued results would be carried forward.
Discharge from liability
The board of directors and the CEO were discharged from liability for the financial year 2021.
Election of the board of directors, auditor and remuneration
The AGM resolved that the board of directors shall comprise of four directors without deputies. The AGM resolved that the number of auditors shall be one registered audit firm.
It was further resolved that the he remuneration is to be SEK 500,000 in total, (SEK 500,000 previous year), and shall be paid to the directors in the following amounts:
· SEK 100,000 (SEK 100,000) for each of the non-employed directors and SEK 200,000 (SEK 200,000) to the chairman.
It was further resolved that remuneration to the auditor shall be paid in accordance with approved invoices.
Lars Björk, Göran Hägglund, Per-Egon Johansson and Mats Lindstrand were re-elected as directors of the board. Mats Lindstrand was also re-elected as chairman of the board.
MAZARS SET Revisionsbyrå AB was re-elected as the Company auditor. MAZARS SET Revisionsbyrå AB has announced that Samuel Bjälkemo will continue to act as main responsible auditor.
For further details regarding the resolutions set out above refer to the complete proposals and annual accounts available at the Company's website, www.frisqholding.se.
About FRISQ:
FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent on your ability to navigate a complex system and constantly evolving treatments. The software solution FRISQ Care enables the creation of personalized, digital care plans that facilitate collaboration and secure information sharing between care teams, doctors and patients through the same platform.
Since 2016, FRISQ has been listed on Nasdaq First North Stockholm under the symbol “FRISQ”. FNCA Sweden AB is FRISQ’s Certified Adviser and can be reached via the following contact information: +46 8 528 00 399, info@fnca.se
The publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.
For more information, please visit: www.frisqholding.se